SorThor. 14 Jun-National Cancer Institute. Sign a clinical study in collaboration with the National Cancer Center of Japan Clinical studies on cancer treatment together Both exchange treatment experiences and drug dispensing, focusing on treatment at the gene level. to inhibit cancer cells
Dr. Thongchai Keeratihuttayakorn Director General of the Medical Department Signed a cancer cooperation agreement with Dr. Hitoshi Nakagama, President of the National Cancer Center. Japan in clinical research studies of drugs and cancer treatment together To make cancer treatment on point By focusing on the treatment of the genes that found that personalized cancer treatment Which is the result of race, dose, in any manner is better treated? by Thai and Japanese people are similar which the cancer group will bring Both breast cancer, lung cancer, colon cancer found in many Thai people. for an international clinical research project to be carried out together this time will use both remote system technology in research to reduce the cost of doing clinical research and has been approved by the medical condition As for the determination of people to participate in the project, it is under consideration. The research study project also receives cooperation from medical schools and the private sector.
Dr. Napa Siriwatanakul, director of the National Cancer Institute, said that cancer treatment has progressed in terms of both drugs and technology, but nowadays, cancer treatment is becoming popular to study cancer treatment at the gene level. for better treatment efficiency and inhibit the recurrence of cancer that may occur after treatment for a while The statistical cancer rate of Thai people is still in the same 3 order of breast cancer in women. lung cancer in men and colon cancer.-Thai News Agency
Source: Thai News Agency